Innovating to improve health worldwide

2026 UN High-Level Meeting on HIV/AIDS

On 22 June 2026, IFPMA delivered a statement at the UN High-Level Meeting on HIV/AIDS in New York. Excellencies, distinguished delegates, I am pleased to speak on behalf of the IFPMA, representing the innovative pharmaceutical industry. As Member States gather at this High-Level Meeting to renew global commitments on HIV/AIDS, IFPMA welcomes the Political Declaration’s...

Pharmaceutical innovation key to delivering G7 leaders’ growth agenda

The global innovative pharmaceutical industry welcomes the G7 leaders’ commitment to strengthening international cooperation and advancing a balanced and durable growth agenda. IFPMA reiterates that a strong life sciences sector is critical to support these shared objectives.

Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment

The global pharmaceutical industry underlines the commitment of the sector to support the response to the latest Ebolavirus outbreak, and calls for the latest outbreak to be a “wake up call” for negotiators discussing the details of the Pandemic Agreement.

High-Level Virtual Meeting of African Heads of States, Governments and Partners on Ebola Bundibugyo virus disease outbreak

IFPMA Statement ahead of the High-Level Meeting of African Heads of State, Governments and Partners on the Ebola Bundibugyo virus disasese outbreak.